Skip to the content
Search
Beyond Type 2
Menu
BEYOND TYPE 2
Show sub menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
Beyond Type 2 App
Marathon Team
En Español
Search
Invisible:
news
ADA 2019 In Review
The biggest diabetes conference of the year — American Diabetes Association’s 79th Annual Scientific Sessions is over, and Beyond Type 2’s editorial staff was reporting live from the conferenc...
Film Review: A Touch of Sugar
A Touch of Sugar may be the title of a documentary about diabetes narrated by Oscar-winning actress Viola Davis, but it actually provides a touch of hope – hope that we can collectively solve the di...
Nutritional Therapy for Adults with Diabetes or Prediabetes: ADA Consensus
Today we know that there is no single approach or nutritional treatment for people with diabetes (any type) or prediabetes
Diabetes Care in Hospitals: An Update
The American Diabetes Association included in its guidelines and overall consensus of 2019, a review and update of intrahospital management of diabetes
New Data Shows FreeStyle Libre Lowers HbA1c in People with T2D
On June 8, Abbott released new data showing the impact of the FreeStyle Libre System on those living with Type 2 diabetes. Research showed that usage significantly reduced hemoglobin A1c (HbA1c) level...
Challenging the Importance of Hypoglycemia in Type 2 Diabetes
A debate between two distinguished professors from the University of Edinburgh and Washington University in St. Louis about the seriousness of hypoglycemia in Type 2 diabetes. Their thoughts just may ...
Breaking News from ADA 2019
Findings from the EMPA-REG OUTCOME® trial found that Jardiance® (empagliflozin) reduces cardiovascular and renal risk in adults with Type 2 diabetes and known cardiovascular disease • The results ...
RISE Clinical Trial: Slowing the Progression of Type 2 Diabetes
The RISE clinical trial revealed the function of beta-cell function in adults with type 2 diabetes or with impaired glucose tolerance (IGT).
Long-Term Effects of Dulaglutide on People with T2D: Results from the REWIND Trial
Researchers reveal the long-term effects of GLP-1 drug on cardiovascular disease in people with type 2 diabetes.
TODAY2 Results: Tracking Type 2 Diabetes in Youth
TODAY was the first multiethnic randomized trial to examine youth-onset Type 2 diabetes. Until the 1990s, cases of Type 2 diabetes (T2D) in children and adolescents were rare. In addition, the increas...
Posts navigation
←
Newer
Posts
1
…
18
19
20
Older
Posts
→